{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:42:21Z","timestamp":1792687341773,"version":"4.5.0"},"reference-count":46,"publisher":"American Chemical Society (ACS)","issue":"1","license":[{"start":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T00:00:00Z","timestamp":1641168000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/N021134\/1"],"award-info":[{"award-number":["EP\/N021134\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MRC\/CIC6\/52"],"award-info":[{"award-number":["MRC\/CIC6\/52"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000294","name":"Medical Research Scotland","doi-asserted-by":"publisher","award":["PHD-1046-2016"],"award-info":[{"award-number":["PHD-1046-2016"]}],"id":[{"id":"10.13039\/501100000294","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000848","name":"University Of Edinburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk??odowska-Curie Actions","doi-asserted-by":"publisher","award":["658833"],"award-info":[{"award-number":["658833"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Chem."],"published-print":{"date-parts":[[2022,1,13]]},"DOI":"10.1021\/acs.jmedchem.1c01733","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:54:22Z","timestamp":1641257662000},"page":"552-561","source":"Crossref","is-referenced-by-count":52,"title":["A 5-FU Precursor Designed to Evade Anabolic and Catabolic Drug Pathways and Activated by Pd Chemistry <i>In Vitro<\/i> and <i>In Vivo<\/i>"],"prefix":"10.1021","volume":"65","author":[{"given":"Catherine","family":"Adam","sequence":"first","affiliation":[{"name":"Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, University of Edinburgh, EH4 2XU Edinburgh, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Bray","sequence":"additional","affiliation":[{"name":"Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, University of Edinburgh, EH4 2XU Edinburgh, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3900-3335","authenticated-orcid":true,"given":"Ana M.","family":"P\u00e9rez-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, University of Edinburgh, EH4 2XU Edinburgh, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ee Hong","family":"Tan","sequence":"additional","affiliation":[{"name":"Institute of Cancer Sciences, University of Glasgow, Bearsden, Glasgow G61 1QH, U.K."},{"name":"Cancer Research UK Beatson Institute, Garscube Estate, Bearsden, Glasgow G61 1BD, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4720-6578","authenticated-orcid":true,"given":"Bel\u00e9n","family":"Rubio-Ruiz","sequence":"additional","affiliation":[{"name":"Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, University of Edinburgh, EH4 2XU Edinburgh, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0859-829X","authenticated-orcid":true,"given":"Daniel J.","family":"Baillache","sequence":"additional","affiliation":[{"name":"Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, University of Edinburgh, EH4 2XU Edinburgh, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3469-1546","authenticated-orcid":true,"given":"Douglas R.","family":"Houston","sequence":"additional","affiliation":[{"name":"Institute of Quantitative Biology, Biochemistry and Biotechnology, University of Edinburgh, Edinburgh EH9 3BF, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Salji","sequence":"additional","affiliation":[{"name":"Institute of Cancer Sciences, University of Glasgow, Bearsden, Glasgow G61 1QH, U.K."},{"name":"Cancer Research UK Beatson Institute, Garscube Estate, Bearsden, Glasgow G61 1BD, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hing Y.","family":"Leung","sequence":"additional","affiliation":[{"name":"Institute of Cancer Sciences, University of Glasgow, Bearsden, Glasgow G61 1QH, U.K."},{"name":"Cancer Research UK Beatson Institute, Garscube Estate, Bearsden, Glasgow G61 1BD, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1029-2855","authenticated-orcid":true,"given":"Asier","family":"Unciti-Broceta","sequence":"additional","affiliation":[{"name":"Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, University of Edinburgh, EH4 2XU Edinburgh, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2022,1,3]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2010.28.15_suppl.e13505"},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1177\/1758835918780140"},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11050199"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.11.008"},{"key":"ref5\/cit5","unstructured":"U.S.\nFood & Drug Administration.  Table\nof pharmacogenetic associations, revised May 24, 2021. https:\/\/www.fda.gov\/medical-devices\/precision-medicine\/table-pharmacogenetic-associations."},{"key":"ref6\/cit6","unstructured":"European\nMedicines Agency.  EMA recommendations\non DPD testing priot\nto treamtment with fluorouracil, capecitabine, tegafur and flucytosine; EMA\/229267\/2020; EMA: Amsterdam, The Netherlands, 2020. https:\/\/www.ema.europa.eu\/en\/news\/ema-recommendations-dpd-testing-prior-treatment-fluorouracil-capecitabine-tegafur-flucytosine."},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2020.10.001"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1021\/acscentsci.1c00124"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26051292"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4277"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201705920"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201404547"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201705609"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15906"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1039\/C8SC02291G"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1038\/srep09329"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.1021\/jm500531z"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.1002\/chem.201803725"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1021\/acs.orglett.8b00423"},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2017.05.036"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c00781"},{"key":"ref22\/cit22","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b01426"},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1038\/s41929-019-0333-4"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2021.116217"},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.1039\/C3SC53317D"},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.1038\/nchem.2284"},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.9b07193"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1038\/s41929-019-0317-4"},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1039\/D0SC04329J"},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.1002\/ange.202111461"},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201609837"},{"key":"ref32\/cit32","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201901760"},{"key":"ref33\/cit33","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.0c01622"},{"key":"ref34\/cit34","doi-asserted-by":"publisher","DOI":"10.1016\/j.chempr.2020.06.002"},{"key":"ref35\/cit35","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.9b00518"},{"key":"ref36\/cit36","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-021-00910-7"},{"key":"ref37\/cit37","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111877200"},{"key":"ref38\/cit38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.23.11064"},{"key":"ref39\/cit39","doi-asserted-by":"publisher","DOI":"10.4236\/jct.2012.31004"},{"key":"ref40\/cit40","doi-asserted-by":"publisher","DOI":"10.1007\/BF00685670"},{"key":"ref41\/cit41","author":"European Medicines Agency","year":"2020","journal-title":"Assessment report: Fluorouracil and fluorouracil related substances (capecitabine, tegafur and flucytosine) containing medicinal products"},{"key":"ref42\/cit42","doi-asserted-by":"publisher","DOI":"10.1093\/toxres\/tfaa081"},{"key":"ref43\/cit43","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkm276"},{"key":"ref44\/cit44","doi-asserted-by":"publisher","DOI":"10.1002\/prot.20660"},{"key":"ref45\/cit45","doi-asserted-by":"publisher","DOI":"10.1186\/1758-2946-3-33"},{"key":"ref46\/cit46","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2016.051"}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.1c01733","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.1c01733","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T12:54:07Z","timestamp":1682513647000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.jmedchem.1c01733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,3]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,13]]}},"alternative-id":["10.1021\/acs.jmedchem.1c01733"],"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.1c01733","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,3]]}}}